Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
66,587,586
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
167,481
-
Shares change
-
+15,103
-
Total reported value, excl. options
-
$520,000
-
Value change
-
+$44,563
-
Number of buys
-
4
-
Number of sells
-
-2
-
Price
-
$3.1
Significant Holders of Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) as of Q1 2020
11 filings reported holding ARMP - Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value as of Q1 2020.
Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 167,481 shares
of 66,587,586 outstanding shares and own 0.25% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (66,727 shares), EDGEWOOD MANAGEMENT LLC (40,000 shares), STIFEL FINANCIAL CORP (22,599 shares), VANGUARD GROUP INC (15,150 shares), SeaCrest Wealth Management, LLC (12,655 shares), BANK OF AMERICA CORP /DE/ (3,065 shares), BANK OF MONTREAL /CAN/ (2,444 shares), UBS Group AG (2,278 shares), MORGAN STANLEY (1,992 shares), and NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO (571 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.